MechanismShilajit

Mitochondria, ATP, and the Shilajit Energy Story

The MYKO Library · 5 Min Read · Jun 18, 2026
Da Vinci-style engraving — mitochondrial cross-section showing inner-membrane cristae

The energy claim is the most commonly made and the most loosely substantiated in the Shilajit category. The underlying chemistry is interesting; the human clinical evidence is thinner than the marketing suggests.

Short answer

The Shilajit "energy story" rests on three threads: in-vitro antioxidant activity, animal-model evidence of HPA-axis modulation and mitochondrial preservation in chronic-fatigue contexts, and proposed mechanisms involving dibenzo-α-pyrones (DBPs) as CoQ10-adjacent electron carriers. The threads are real research; they don't add up to "Shilajit boosts ATP in humans" at clinical-trial evidence levels. Structure-function language is honest; outcome language overclaims.


The proposed mechanism, walked carefully

The mitochondrial story for Shilajit has four steps. Each step is supported by some evidence; the chain as a whole is mechanism-plausible rather than clinically-confirmed.

Step 1: Shilajit contains DBPs, which are CoQ10-related

Dibenzo-α-pyrones share part of CoQ10's quinone-ring chemistry. CoQ10 is the electron carrier in mitochondrial complex I→III electron transport. DBPs may perform a similar function or augment CoQ10's lifetime in the membrane. Evidence: structural characterization is well-established; functional equivalence is hypothesis. (Agarwal 2007; Stohs 2013)

Step 2: Shilajit shows antioxidant activity in vitro

The combined fulvic acid + humic acid + DBP fractions show direct radical-scavenging activity in cell and chemical assays. Mitochondrial respiration produces reactive oxygen species (ROS) as a normal byproduct. A persistent oxidative environment damages mitochondrial DNA and proteins; antioxidant defense supports mitochondrial function. (Stohs 2013)

Step 3: Animal models show fatigue-related benefit

Surapaneni 2012, an animal model of chronic fatigue syndrome, showed that Shilajit administration was associated with preserved mitochondrial function and HPA-axis modulation. The animals receiving Shilajit showed less fatigue-related behavior. (Surapaneni 2012)

Step 4: Inferred human translation

The leap from "in-vitro antioxidant + animal model fatigue reduction + DBP structural similarity to CoQ10" to "Shilajit boosts ATP in humans" is the part that's not confirmed by current human clinical data. This is where the mechanism story crosses into claim territory.

What the published research does NOT show

Honest list of claims that get made about Shilajit and mitochondrial function that are NOT adequately supported by current published evidence:

  • "Shilajit increases ATP production by X%" — no human clinical trial measuring ATP directly in supplement-dose Shilajit users
  • "Shilajit improves mitochondrial function" — supported in animal models; not confirmed in humans at the cellular-bioenergetic level
  • "Shilajit reverses age-related mitochondrial decline" — no clinical evidence
  • "Shilajit increases CoQ10 levels" — proposed mechanism; no clinical trial measuring serum CoQ10 in Shilajit-supplemented users
  • "Shilajit improves athletic performance" — limited evidence; mostly small studies with mixed results [verify against current PubMed]

A brand making any of these claims as a structure-function statement is overstating the evidence base. The honest version of these claims uses qualifiers like "proposed mechanism," "in animal models," "characterized in vitro" — language that some brands do use, and that the FDA/DSHEA framework explicitly contemplates.

What CAN be honestly said about Shilajit and energy

Defensible structure-function framing:

  • "Shilajit has been characterized in traditional Ayurvedic medicine as a rasayana — a rejuvenator and adaptogen. Modern research describes characterized antioxidant and adaptogenic activity. (Stohs 2013)"
  • "Dibenzo-α-pyrones in Shilajit have structural similarity to coenzyme Q10 and are proposed to support mitochondrial function. (Agarwal 2007)"
  • "Animal models of chronic fatigue have shown Shilajit-associated effects on HPA-axis modulation and mitochondrial preservation. (Surapaneni 2012)"
  • "In traditional use, Shilajit is described as a tonic with effects that develop slowly over weeks of consistent intake — not an acute energizer."

What sets this framing apart from overclaim is the qualifying language and the citation pattern. The mechanism is plausible; the clinical confirmation in humans is the part that requires honesty.

Why the "slow tonic" framing actually matters

Most Shilajit users who report subjective energy effects describe them as cumulative over weeks, not acute within minutes. This is consistent with three mechanisms:

1. Antioxidant accumulation. Daily intake of antioxidant compounds builds antioxidant defense capacity over time. The effect is gradual; users notice fatigue resilience rather than acute alertness.

2. Mineral-status improvement. If Shilajit's iron, magnesium, and trace mineral contributions are filling small nutritional gaps, the bioenergetic effect manifests as gradual improvement in conditions where mineral inadequacy was limiting function.

3. HPA-axis modulation. Adaptogenic effects on stress-response systems manifest as resilience to fatigue triggers, not as direct energy production. This is the most consistent framing across the published literature.

What Shilajit isn't, even in the honest framing:

  • An acute stimulant (no caffeine, no theobromine, no acute neurological activator)
  • A substitute for direct CoQ10 supplementation in conditions where CoQ10 is specifically indicated
  • A treatment for any clinical fatigue disorder (in regulatory language)

The CoQ10 question, specifically

Three honest things to say about Shilajit and CoQ10:

  1. DBPs and CoQ10 are structurally related. This is chemistry, not marketing.
  2. The functional relationship is proposed. Whether DBPs spare, regenerate, or augment CoQ10 in mitochondrial membranes is mechanism hypothesis with some in-vitro support.
  3. A Shilajit supplement is not equivalent to a CoQ10 supplement. If you need CoQ10 (e.g., on statin therapy, with specific deficiency contexts), take CoQ10. Shilajit complements; it doesn't substitute.

For the longer treatment of DBP chemistry, see Dibenzo-α-pyrones: Shilajit's Signature Compound.

What the current state of evidence actually warrants

For the customer thinking about whether to take Shilajit for energy:

  • If you're looking for acute energy: Caffeine, mate, guarana, and similar acute stimulants will do that. Shilajit won't.
  • If you're looking for fatigue resilience over weeks: Shilajit is a defensible part of a broader protocol, alongside sleep, mineral adequacy, and stress management. Evaluate over a 4–8 week window.
  • If you have a specific bioenergetic condition: Talk to a clinician. Shilajit is a supplement; bioenergetic conditions warrant clinical assessment.
  • If you're stacking with CoQ10: No known contraindication. The two may complement each other; they don't substitute. [verify CoQ10-Shilajit interaction literature]

The honest brand position: Shilajit's energy story is real chemistry, plausibly translated to human structure-function effects, with the strongest framing being "tonic adaptogen with antioxidant and mineral contributions over time," not "ATP booster."

FAQ

Does Shilajit really increase ATP production? The mechanism is proposed; direct human clinical trials measuring ATP in Shilajit users are limited. The honest version of this claim is "Shilajit has been characterized as mitochondrial-supportive in proposed mechanism and animal models." Treat any product claiming a specific ATP-percentage increase as overstating the evidence.

Will I feel Shilajit on the first day? Probably not. Most users describe the effect as cumulative over weeks. If you feel something acute on day one, it's likely placebo, attention to the new ritual, or an interaction with another supplement you're taking.

Is Shilajit a stimulant? No. It contains no caffeine, theobromine, or other acute stimulants. The effects, where present, are described as tonic and adaptogenic — not acute alertness.

Can I take Shilajit with CoQ10? Generally yes. The two may have complementary mechanisms. The combination doesn't have known contraindications, though anyone on therapy involving either compound should discuss the addition with their clinician.

Why don't more athletes use Shilajit if it boosts energy? Because the published evidence for athletic performance enhancement is limited and mixed. Athletes who do use Shilajit often do so as part of broader recovery and adaptogen protocols, not for acute performance.

How long until I feel something? Most reported subjective effects develop over 2–6 weeks of consistent daily use. If you don't notice anything after 8 weeks at a reasonable dose, Shilajit may not be doing for you what it does for others. (How to Use →)


Read next


References

  1. Agarwal SP, et al. Shilajit: a review. Phytother Res. 2007. doi.org/10.1002/ptr.2100
  2. Wilson E, et al. Review on shilajit used in traditional Indian medicine. J Ethnopharmacol. 2011. doi.org/10.1016/j.jep.2011.04.033
  3. Surapaneni DK, et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome… J Ethnopharmacol. 2012. doi.org/10.1016/j.jep.2012.06.002
  4. Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytother Res. 2013. doi.org/10.1002/ptr.5018

Tonic, not stimulant. Evaluate over weeks. Shop Resin → · Shop Powder →

01
The Daily-Foundation Formula
ADAPT
The formula this piece connects to — mechanism-led, properly dosed, disclosed by name.
Shop →
From The Library

The MYKO Library

Mechanism-led essays on functional mushrooms, cofactors, and the slow architecture of wellness. Built for people who stay.

About MYKO →
The MYKO Formulations

Formulated for the system, not the search results.

Five precision formulas — dual-extracted fruiting body, well-formed cofactors, every ingredient disclosed by name. Built for people whose work depends on a steady mind.

01 MYKO